Free Trial

Ovid Therapeutics (OVID) Short Interest Ratio & Short Volume

Ovid Therapeutics logo
$0.62 +0.05 (+8.91%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.62 +0.01 (+1.21%)
As of 02/21/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Short Interest Data

Ovid Therapeutics (OVID) has a short interest of 883,700 shares, representing 1.59% of the float (the number of shares available for trading by the public). This marks a 25.26% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 441,937 shares to cover all short positions.

Current Short Interest
883,700 shares
Previous Short Interest
705,500 shares
Change Vs. Previous Month
+25.26%
Dollar Volume Sold Short
$586,246.58
Short Interest Ratio
2.4 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
71,010,000 shares
Float Size
55,620,000 shares
Short Percent of Float
1.59%
Today's Trading Volume
577,971 shares
Average Trading Volume
441,937 shares
Today's Volume Vs. Average
131%
Short Selling Ovid Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Ovid Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OVID Short Interest Over Time

OVID Days to Cover Over Time

OVID Percentage of Float Shorted Over Time

Ovid Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2025883,700 shares $586,246.58 +25.3%1.6%2.4 $0.66
1/15/2025705,500 shares $537,449.90 +2.0%1.3%2.4 $0.76
12/31/2024692,000 shares $646,120.40 -27.0%1.2%2.7 $0.93
12/15/2024947,800 shares $976,234.00 +28.0%1.7%4.5 $1.03
11/30/2024740,300 shares $843,942.00 -2.1%1.3%4.2 $1.14
11/15/2024756,500 shares $801,890.00 +11.3%1.4%4.4 $1.06
10/31/2024679,900 shares $768,287.00 +12.0%1.2%3.8 $1.13
10/15/2024606,900 shares $697,935.00 -4.3%1.0%3.4 $1.15
9/30/2024633,900 shares $748,002.00 -3.1%1.1%2.8 $1.18
9/15/2024653,900 shares $778,141.00 -9.3%1.1%1.4 $1.19
8/31/2024721,300 shares $815,069.00 -10.2%1.2%0.8 $1.13
8/15/2024803,200 shares $907,616.00 -24.9%1.4%0.9 $1.13
7/31/20241,070,000 shares $1.11 million -2.7%1.9%1.2 $1.04
7/15/20241,100,000 shares $1.03 million +6.8%1.9%1.3 $0.94
6/30/20241,030,000 shares $792,276.00 -64.0%1.8%1.2 $0.77
6/15/20242,860,000 shares $9.41 million -0.4%5.0%4.1 $3.29
5/31/20242,870,000 shares $8.78 million +0.7%5.0%15.2 $3.06
5/15/20242,850,000 shares $9.46 million +1.1%5.0%14.6 $3.32
4/30/20242,820,000 shares $8.60 million +0.7%4.8%13.7 $3.05
4/15/20242,800,000 shares $8.96 million No Change4.8%13.4 $3.20
3/31/20242,800,000 shares $8.54 million -23.7%4.8%13.7 $3.05
3/15/20243,670,000 shares $9.98 million +0.6%6.3%17.4 $2.72
2/29/20243,650,000 shares $12.41 million +1.4%6.2%22.9 $3.40
2/15/20243,600,000 shares $13.10 million +7.8%6.1%23.9 $3.64
1/31/20243,340,000 shares $12.93 million +8.4%5.6%23.5 $3.87
1/15/20243,080,000 shares $9.64 million +6.2%5.2%21.9 $3.13
12/31/20232,900,000 shares $9.34 million +16.9%4.9%21.3 $3.22
12/15/20232,480,000 shares $8.53 million +7.8%4.2%18.2 $3.44
11/30/20232,300,000 shares $6.84 million +7.5%3.9%19.2 $2.98
11/15/20232,140,000 shares $7.19 million +6.5%3.7%18 $3.36
10/31/20232,010,000 shares $7.14 million +2.6%3.5%13.2 $3.55
10/15/20231,960,000 shares $7.19 million -5.3%3.4%12.3 $3.67
9/30/20232,070,000 shares $7.95 million +2.0%3.6%13.4 $3.84
9/15/20232,030,000 shares $8.06 million -2.4%3.5%11.9 $3.97
8/31/20232,080,000 shares $7.00 million +12.4%3.6%6.6 $3.37
8/15/20231,850,000 shares $6.64 million +1.1%3.2%5.9 $3.59
7/31/20231,830,000 shares $6.57 million -0.5%3.1%6.3 $3.59
7/15/20231,840,000 shares $6.24 million No Change3.3%6.4 $3.39
6/30/20231,840,000 shares $6.04 million +216.7%3.3%6.4 $3.28
6/15/2023581,000 shares $2.08 million +40.2%1.0%2.2 $3.58
How to trade Executive Order 14154 (Ad)

Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orders. Among this blizzard of directives – ranging from slapping 25% tariffs on steel to banning the forced use of paper straws… Everyone seems to have missed the most important detail of all.

Get the true, untold story of what’s hidden inside Executive Order 14154, here.
5/31/2023414,500 shares $1.47 million +28.7%0.7%3.3 $3.54
5/15/2023322,100 shares $1.12 million +62.3%0.6%3.2 $3.49
4/30/2023198,500 shares $710,630.00 -7.2%0.4%2.2 $3.58
4/15/2023213,900 shares $663,090.00 +2.6%0.4%2.9 $3.10
3/31/2023208,500 shares $537,930.00 -9.8%0.4%3 $2.58
3/15/2023231,200 shares $483,208.00 -5.5%0.4%3.3 $2.09
2/28/2023244,600 shares $604,162.00 +9.1%0.4%2.7 $2.47
2/15/2023224,300 shares $567,479.00 -1.1%0.4%2.6 $2.53
1/31/2023226,700 shares $566,750.00 +3.1%0.4%2.6 $2.50
1/15/2023219,800 shares $523,124.00 +2.9%0.4%2.5 $2.38
12/30/2022213,600 shares $397,296.00 -24.7%0.4%1.8 $1.86
12/15/2022283,500 shares $510,300.00 +4.5%0.5%2.4 $1.80
11/30/2022271,200 shares $480,024.00 -5.8%0.5%2.6 $1.77
11/15/2022287,800 shares $483,504.00 +3.6%0.5%2.8 $1.68
10/31/2022277,700 shares $452,651.00 -3.7%0.5%2.6 $1.63
10/15/2022288,300 shares $449,748.00 +1.8%0.5%2.6 $1.56
9/30/2022283,100 shares $520,904.00 +1.9%0.5%3.1 $1.84
9/15/2022277,800 shares $608,382.00 -3.5%0.5%2.7 $2.19
8/31/2022287,800 shares $578,478.00 +2.5%0.5%2.1 $2.01
8/15/2022280,800 shares $634,608.00 -6.8%0.5%1.6 $2.26
7/31/2022301,200 shares $617,460.00 -11.7%0.5%1.7 $2.05
7/15/2022341,100 shares $689,022.00 -6.9%0.7%1.9 $2.02
6/30/2022366,400 shares $787,760.00 -9.4%0.7%2 $2.15
6/15/2022404,500 shares $728,100.00 -31.7%0.8%2.1 $1.80
5/31/2022592,200 shares $1.00 million -5.5%1.1%3.3 $1.69
5/15/2022626,400 shares $1.37 million -6.9%1.2%3.9 $2.19
4/30/2022672,700 shares $1.85 million -5.6%1.3%4.4 $2.75
4/15/2022712,800 shares $2.29 million -3.0%1.4%3.9 $3.21
3/31/2022735,000 shares $2.31 million +0.3%1.4%3.7 $3.14
3/15/2022733,000 shares $2.29 million +5.3%1.4%3.7 $3.13
2/28/2022696,000 shares $2.36 million +7.2%1.4%3.2 $3.39
2/15/2022649,000 shares $2.08 million -9.2%1.3%3 $3.21
1/31/2022715,000 shares $1.97 million -0.5%1.4%3.1 $2.76
1/15/2022718,800 shares $2.25 million -3.9%1.5%3.3 $3.13
12/31/2021748,200 shares $2.40 million +4.1%1.5%3.6 $3.21
12/15/2021718,600 shares $2.31 million -4.1%1.5%3.1 $3.21
11/30/2021749,200 shares $2.51 million +13.0%1.5%3.4 $3.35
11/15/2021663,000 shares $2.41 million -39.2%1.3%2.7 $3.64
10/29/20211,090,000 shares $3.71 million -4.4%2.2%4.1 $3.40
10/15/20211,140,000 shares $4.10 million +10.7%2.3%4.1 $3.60
9/30/20211,030,000 shares $3.46 million -13.5%2.1%3.4 $3.36
9/15/20211,190,000 shares $4.12 million -26.5%2.5%2.7 $3.46
8/31/20211,620,000 shares $5.72 million -4.1%3.5%3.1 $3.53
8/13/20211,690,000 shares $6.83 million +3.7%3.6%2.8 $4.04
7/30/20211,630,000 shares $6.08 million -1.2%3.5%2.4 $3.73
7/15/20211,650,000 shares $6.09 million -1.2%3.5%2.2 $3.69
6/30/20211,670,000 shares $6.53 million -52.6%3.6%2 $3.91
6/15/20213,520,000 shares $15.52 million +0.6%6.5%4.4 $4.41
5/28/20213,500,000 shares $14.53 million -6.2%6.5%3.7 $4.15
5/14/20213,730,000 shares $12.31 million -11.8%N/A1.2 $3.30
How to trade Executive Order 14154 (Ad)

Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orders. Among this blizzard of directives – ranging from slapping 25% tariffs on steel to banning the forced use of paper straws… Everyone seems to have missed the most important detail of all.

Get the true, untold story of what’s hidden inside Executive Order 14154, here.
4/30/20214,230,000 shares $16.37 million -10.2%N/A1.2 $3.87
4/15/20214,710,000 shares $18.13 million -18.5%N/A1.2 $3.85
3/31/20215,780,000 shares $22.25 million -29.1%N/A1.4 $3.85
3/15/20218,150,000 shares $33.42 million +153.1%N/A2 $4.10
2/26/20213,220,000 shares $9.50 million +17.1%8.4%0.7 $2.95
2/12/20212,750,000 shares $9.19 million -6.5%7.2%1.2 $3.34
1/29/20212,940,000 shares $7.67 million -8.4%8.2%1.4 $2.61
1/15/20213,210,000 shares $8.25 million -7.2%8.9%1.8 $2.57
12/31/20203,460,000 shares $8.23 million -10.1%9.6%2.3 $2.38
12/15/20203,850,000 shares $10.16 million +11.3%10.7%2.8 $2.64
11/30/20203,460,000 shares $21.76 million +13.4%9.6%3.1 $6.29
11/15/20203,050,000 shares $18.42 million +15.1%8.5%3.2 $6.04
10/30/20202,650,000 shares $13.91 million +0.8%6.9%2.8 $5.25
10/15/20202,630,000 shares $14.96 million -38.0%6.9%2.7 $5.69
9/30/20204,240,000 shares $24.34 million +20.8%11.1%4.2 $5.74
9/15/20203,510,000 shares $22.50 million -22.5%9.9%2.9 $6.41
8/31/20204,530,000 shares $26.00 million +51.0%12.7%2.8 $5.74
8/14/20203,000,000 shares $22.50 million +2.7%9.7%1.8 $7.50
7/31/20202,920,000 shares $18.83 million +15.4%9.5%2 $6.45
7/15/20202,530,000 shares $18.60 million -30.1%8.6%1.7 $7.35
6/30/20203,620,000 shares $26.68 million +170.2%12.3%2.5 $7.37
6/15/20201,340,000 shares $7.60 million +58.6%4.6%1.1 $5.67
5/29/2020844,800 shares $4.52 million -37.4%2.9%1 $5.35
5/15/20201,350,000 shares $5.55 million -18.2%4.6%1.7 $4.11
4/30/20201,650,000 shares $6.01 million +20.4%5.7%2.7 $3.64
4/15/20201,370,000 shares $4.64 million +8.7%4.7%2.5 $3.39
3/31/20201,260,000 shares $4.30 million -43.2%4.4%2.2 $3.41
3/13/20202,216,300 shares $6.29 million +21.8%9.8%3.5 $2.84
2/28/20201,820,000 shares $4.40 million +94.6%8.0%2.7 $2.42

OVID Short Interest - Frequently Asked Questions

What is Ovid Therapeutics' current short interest?

Short interest is the volume of Ovid Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 883,700 shares of OVID short. 1.59% of Ovid Therapeutics' shares are currently sold short. Learn More on Ovid Therapeutics' current short interest.

What is a good short interest ratio for Ovid Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OVID shares currently have a short interest ratio of 2.0. Learn More on Ovid Therapeutics's short interest ratio.

Which institutional investors are shorting Ovid Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ovid Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ovid Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.59% of Ovid Therapeutics' floating shares are currently sold short.

Is Ovid Therapeutics' short interest increasing or decreasing?

Ovid Therapeutics saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 883,700 shares, an increase of 25.3% from the previous total of 705,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ovid Therapeutics' float size?

Ovid Therapeutics currently has issued a total of 71,010,000 shares. Some of Ovid Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ovid Therapeutics currently has a public float of 55,620,000 shares.

How does Ovid Therapeutics' short interest compare to its competitors?

1.59% of Ovid Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ovid Therapeutics: Lyell Immunopharma, Inc. (7.64%), Zentalis Pharmaceuticals, Inc. (6.81%), CARGO Therapeutics, Inc. (18.87%), Vaxart, Inc. (4.88%), Acrivon Therapeutics, Inc. (5.01%), Cidara Therapeutics, Inc. (2.97%), Alector, Inc. (7.25%), Aclaris Therapeutics, Inc. (5.49%), Greenwich LifeSciences, Inc. (10.90%), Innate Pharma S.A. (0.18%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Ovid Therapeutics stock?

Short selling OVID is an investing strategy that aims to generate trading profit from Ovid Therapeutics as its price is falling. OVID shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ovid Therapeutics?

A short squeeze for Ovid Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OVID, which in turn drives the price of the stock up even further.

How often is Ovid Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OVID, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:OVID) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners